MedTrace Logo

Prothrombotic Biomarkers and Ovarian Stimulation

NCT04188444 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2020-11-12

No results posted yet for this study

Summary

The aim of this study is to assess the impact of different protocols used for ovarian stimulation during in vitro fertilization procedures (IVF) on prothrombotic biomarkers (blood coagulation markers associated with thromboembolic events) in the units of reproductive medicine in two university hospitals (HUG, Geneva and CHUV, Lausanne).

Conditions

  • Sterility, Female
  • Reproductive Technology, Assisted

Interventions

BIOLOGICAL

Blood test

20 ml of blood, three times

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Justine Hugon-Rodin, MD, PHD · Hôpitaux de Paris, Université de Paris

  • Alessandro Casini, MD · University Hospital, Geneva

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-03-01
Completion
2020-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04188444 on ClinicalTrials.gov